JP2020533296A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533296A5 JP2020533296A5 JP2020513603A JP2020513603A JP2020533296A5 JP 2020533296 A5 JP2020533296 A5 JP 2020533296A5 JP 2020513603 A JP2020513603 A JP 2020513603A JP 2020513603 A JP2020513603 A JP 2020513603A JP 2020533296 A5 JP2020533296 A5 JP 2020533296A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- predopidine
- levodopa
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims 9
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims 9
- 229960004502 levodopa Drugs 0.000 claims 9
- 208000012661 Dyskinesia Diseases 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- 208000018737 Parkinson disease Diseases 0.000 claims 3
- 206010003591 Ataxia Diseases 0.000 claims 1
- 208000012639 Balance disease Diseases 0.000 claims 1
- 206010008748 Chorea Diseases 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 claims 1
- 208000014094 Dystonic disease Diseases 0.000 claims 1
- 208000005622 Gait Ataxia Diseases 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 206010034010 Parkinsonism Diseases 0.000 claims 1
- 208000012601 choreatic disease Diseases 0.000 claims 1
- 230000001934 delay Effects 0.000 claims 1
- 208000010118 dystonia Diseases 0.000 claims 1
- 230000001788 irregular Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762556314P | 2017-09-08 | 2017-09-08 | |
| US62/556,314 | 2017-09-08 | ||
| US201862649184P | 2018-03-28 | 2018-03-28 | |
| US62/649,184 | 2018-03-28 | ||
| PCT/US2018/048920 WO2019050775A1 (en) | 2017-09-08 | 2018-08-30 | PRIDOPIDINE FOR THE TREATMENT OF DYSKINESIC INDUCED BY A MEDICINAL PRODUCT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533296A JP2020533296A (ja) | 2020-11-19 |
| JP2020533296A5 true JP2020533296A5 (https=) | 2021-03-04 |
Family
ID=63684481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020513603A Pending JP2020533296A (ja) | 2017-09-08 | 2018-08-30 | 薬物誘発性ジスキネジアを治療するためのプリドピジン |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190231768A1 (https=) |
| EP (1) | EP3678664A1 (https=) |
| JP (1) | JP2020533296A (https=) |
| CN (1) | CN111343982A (https=) |
| AU (1) | AU2018329628B2 (https=) |
| BR (1) | BR112020004622A2 (https=) |
| CA (1) | CA3075020C (https=) |
| IL (1) | IL273044A (https=) |
| MX (1) | MX383462B (https=) |
| WO (1) | WO2019050775A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013536825A (ja) | 2010-09-03 | 2013-09-26 | イバックス・インターナショナル・ゲーエムベーハー | ドパミン作動性安定化剤として有用なプリドピジンの重水素化類似体 |
| US11090297B2 (en) | 2013-06-21 | 2021-08-17 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating huntington's disease |
| CA3035099C (en) | 2016-08-24 | 2023-01-17 | Prilenia Therapeutics Development Ltd. | Use of pridopidine for treating dystonias |
| US12102627B2 (en) | 2016-09-16 | 2024-10-01 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for treating rett syndrome |
| CN113395964A (zh) | 2019-02-04 | 2021-09-14 | 普瑞尼亚神经治疗有限公司 | 用于帕金森氏病和与帕金森症相关的其它疾病的低剂量普利多匹定 |
| KR102906269B1 (ko) | 2023-08-03 | 2026-01-02 | 재단법인대구경북과학기술원 | 파킨슨 환자의 lid 발병 예측을 위한 정보제공방법 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904724D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
| USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
| CA2584831C (en) | 2004-10-13 | 2013-09-17 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
| SE529246C2 (sv) * | 2005-10-13 | 2007-06-12 | Neurosearch Sweden Ab | Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission |
| CN101711236B (zh) | 2007-04-12 | 2012-10-31 | Nsab神经研究瑞典公司分公司 | 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物 |
| WO2008155357A2 (en) * | 2007-06-18 | 2008-12-24 | A. Carlsson Research Ab | Use of dopamine stabilizers |
| US20110206782A1 (en) | 2010-02-24 | 2011-08-25 | Auspex Pharmaceuticals, Inc. | Piperidine modulators of dopamine receptor |
| WO2011107583A1 (en) | 2010-03-04 | 2011-09-09 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders |
| JP2013532233A (ja) | 2010-07-02 | 2013-08-15 | アクティエボラゲット・エスコーエッフ | 機械構成要素、および表面硬化方法 |
| JP2013536825A (ja) | 2010-09-03 | 2013-09-26 | イバックス・インターナショナル・ゲーエムベーハー | ドパミン作動性安定化剤として有用なプリドピジンの重水素化類似体 |
| BR112014005389A8 (pt) | 2011-09-07 | 2018-04-03 | Ivax Int Gmbh | Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal |
| TWI579272B (zh) * | 2011-12-08 | 2017-04-21 | 梯瓦製藥國際有限責任公司 | 普多比啶（ｐｒｉｄｏｐｉｄｉｎｅ）之氫溴酸鹽 |
| AU2013243461A1 (en) | 2012-04-04 | 2014-11-06 | Teva Pharmaceuticals International Gmbh | Pharmaceutical compositions for combination therapy |
| HK1221646A1 (zh) | 2013-06-21 | 2017-06-09 | Teva Pharmaceuticals International Gmbh | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 |
| DK177976B8 (en) | 2013-07-10 | 2021-04-22 | Jasopels As | Apparatus and method for stretching a pelt on a pelt board |
| MX377576B (es) | 2014-01-22 | 2025-03-04 | Prilenia Neurotherapeutics Ltd | Formulaciones de pridopidina de liberación modificada. |
| JP6526695B6 (ja) | 2014-03-10 | 2019-06-26 | アプライド マテリアルズ インコーポレイテッドＡｐｐｌｉｅｄ Ｍａｔｅｒｉａｌｓ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 多重荷電粒子ビームリソグラフィのためのピクセルブレンディング |
| TW201613859A (en) | 2014-06-30 | 2016-04-16 | Teva Pharma | Analogs of PRIDOPIDINE, their preparation and use |
| MX2017008136A (es) | 2014-12-22 | 2018-03-06 | Teva Pharmaceuticals Int Gmbh | Sal de l-tartrato de pridopidina. |
| JP6887952B2 (ja) | 2015-02-25 | 2021-06-16 | プリレニア ニューロセラピューティクス リミテッド | 認知機能を改善するため、およびアルツハイマー病を治療するためのプリドピジンの使用 |
| EP3324967A4 (en) | 2015-07-22 | 2019-03-20 | Prilenia Therapeutics Development Ltd. | PRIDOPIDINE-BASED FORMULATIONS AND USE OF THE SAME |
| AR105434A1 (es) | 2015-07-22 | 2017-10-04 | Teva Pharmaceuticals Int Gmbh | Proceso para preparar pridopidina |
| JP7034488B2 (ja) | 2016-02-24 | 2022-03-14 | プリレニア・ニューロセラピューティクス・エルティーディー | プリドピジンを使用する神経変性眼疾患の治療 |
| CA3035099C (en) | 2016-08-24 | 2023-01-17 | Prilenia Therapeutics Development Ltd. | Use of pridopidine for treating dystonias |
| EP4516356A3 (en) | 2016-08-24 | 2025-05-14 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for treating functional decline |
| CN109952100A (zh) | 2016-09-15 | 2019-06-28 | 普瑞尼亚医疗发展有限公司 | 普利多匹定用于治疗焦虑和抑郁的用途 |
| WO2018053275A1 (en) | 2016-09-16 | 2018-03-22 | Teva Pharmaceuticals International Gmbh | Use of pridopidine for the treatment of familial dysautonomia |
| CA3050700C (en) | 2017-01-20 | 2023-10-03 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for the treatment of fragile x syndrome |
| SI4154882T1 (sl) | 2017-08-14 | 2026-01-30 | Prilenia Neurotherapeutics Ltd. | Zdravljenje amiotrofične lateralne skleroze s pridopidinom |
| CA3073568A1 (en) * | 2017-08-30 | 2019-03-07 | Prilenia Neurotherapeutics Ltd. | High concentration dosage forms of pridopidine |
| DE102018204527A1 (de) | 2017-09-18 | 2019-03-21 | SEs Solutions GmbH | Dachhalterung für ein Automobil |
-
2018
- 2018-08-30 JP JP2020513603A patent/JP2020533296A/ja active Pending
- 2018-08-30 MX MX2020002645A patent/MX383462B/es unknown
- 2018-08-30 CN CN201880072818.0A patent/CN111343982A/zh active Pending
- 2018-08-30 BR BR112020004622-1A patent/BR112020004622A2/pt not_active IP Right Cessation
- 2018-08-30 WO PCT/US2018/048920 patent/WO2019050775A1/en not_active Ceased
- 2018-08-30 EP EP18778648.8A patent/EP3678664A1/en active Pending
- 2018-08-30 CA CA3075020A patent/CA3075020C/en active Active
- 2018-08-30 AU AU2018329628A patent/AU2018329628B2/en active Active
-
2019
- 2019-04-08 US US16/377,577 patent/US20190231768A1/en not_active Abandoned
- 2019-06-11 US US16/436,947 patent/US11000519B2/en active Active
-
2020
- 2020-03-03 IL IL273044A patent/IL273044A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533296A5 (https=) | ||
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| FI2629097T1 (fi) | Nrf2-seulontatestejä ja niihin liittyviä menetelmiä ja koostumuksia | |
| JP2010518122A5 (https=) | ||
| JP2019503365A5 (https=) | ||
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| JP2019515884A5 (https=) | ||
| AU2012284627A8 (en) | Method for manufacturing a pharmaceutical composition in the form of extended-release tablets containing Pirfenidone and use thereof in the regression of chronic renal insufficiency, breast capsular contracture and hepatic fibrosis in humans | |
| JP2013529665A5 (https=) | ||
| JP2018527305A5 (https=) | ||
| JP2018500300A (ja) | パーキンソン病を遅延させるための医薬 | |
| RU2010107843A (ru) | Бупропиона гидробромид и его терапевтические применения | |
| RU2004132856A (ru) | Фармацевтический препарат с модифицированным высвобождением | |
| JP2022554276A5 (https=) | ||
| RU2011152105A (ru) | Составы таблеток 3-цианохинолина и их применение | |
| JP2019218379A5 (https=) | ||
| JP2020522560A5 (https=) | ||
| JP2016530238A5 (https=) | ||
| RU2018146504A (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| AU2018282104A1 (en) | Use of vibegron to treat overactive bladder | |
| JP2014520856A5 (https=) | ||
| IL272834B2 (en) | Amantadine compositions, preparations thereof, and methods of use | |
| JP2016528171A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| JP2020531543A5 (https=) |